DatasetName,PTOV1_S(36),PTOV1_S(34) PTOV1_S(73),PTOV1_S(40) PTOV1_S(53)
RM2024_Intensity D4-1___3,,,
RB2022_4_PostEndurance,,,
FSO2013_Ratio M/L normalized Rep3,0.2797270164489585,,0.5124125743188952
SR2019_MCF7_Biol_repl_3,,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),0.7190540315676046,,0.6094698088465365
SR2019_LM2_Biol_repl_1,,,
RCJD2014_15min_1,,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,,
CK2022_7 16-1,,,
NJH2025_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_C,,,
RKK2015_TNF-α/basal,0.6001980189341476,,0.6379655024317941
JJ2018_Ratio H/M normalized pP2,,,
NJH2025_Sub12_MICT_Pre,,,
NJH2025_Sub7_MICT_Post,,,
DL2023_control-3,,,
ZX2022_Control Replicate 2,,,
HS2024_6_B_T3,0.5161949666787485,,0.562615303403821
JW2015_Intensity pre1,,,
IMM2018_normalised rep. int. Empty-3,,,
AMK2021_30R_p5,,,
FSO2013_Ratio M/L normalized Rep1,0.7496739519902051,,0.5112442823067657
SR2019_MDAMB231_Biol_repl_4,,,
GF2025_P2_Sph,0.4559331294419635,,0.5649517857095793
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,,
NJH2025_Sub13_HIIT_Mid,,,
CP2009_Ratio M/L,,,
NJH2025_Sub7_HIIT_Post,,,
KBE2022_Log2_Ex_44_T,,,
DB2022_Intensity L2,,,
TM2022_mock.4h.C,0.4669954533634687,,0.5359143362950973
AST2020_anti-CD3.2,,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,,
HS2024_7_B_N1,0.4867308159309967,,0.566516331268639
FSO2013_Ratio M/L normalized Rep1___1,0.7505663546653986,,0.5122935843454609
SAS2015_AZD/DMSO_Exp3,,,
RM2024_Intensity D0-2___3,,,
RM2024_Intensity D6-1,,,
RB2022_8_RecoverySprint,,,
RB2022_5_PreEndurance,,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,0.5844383438354323,,
EP2017_Untreated R#4 normalized log2 ratio,,,
WZ2023_Pu_010_30min,0.6351436791113554,0.49196865889827446,0.5898790406437571
AS2011_Ratio H/L Proteins RNAi_2,,,
RB2022_4_PreStrength,,,
NJH2024_Sub4_MICT_Post,,,
AH2018_LFQ_M_1_X,,0.5005585766869326,
RB2022_8_RecoveryEndurance,,,
KBE2022_Log2_Ex_14_U,,,
FSO2013_Ratio M/L normalized Rep3___3,,,
AH2018_TMTMS3_1_C,,,
JJ2018_Ratio H/L normalized___1,,,
ZQ2022_C2,,,
RB2022_5_PreSprint,,,
PG2020_Intensity 8h_C,,,
AH2018_SILAC_MR_2_N,,,
MV2014_Ratio M/L normalized A1___2 (2 min),,,
TM2022_S2.8h.B,0.4469651378620419,,0.524414273644984
MV2014_Ratio M/H normalized B3___1 (30 min),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,,
RM2024_Intensity D6-1___2,,,
NJH2025_Sub7_MICT_Mid,,,
LY2019_P1+,0.548251699756869,,0.4619072714711917
AS2011_Ratio H/L Proteins Inhi_2,,,
BS2014_Log2(Ratio H/L normalized),0.3648793022064923,,0.4127563430569382
UK2020_HCM_2,,,
FSO2013_Ratio H/L normalized Rep2___2,,,
EP2017_Pervanadate R#3 normalized log2 ratio,,,
RM2024_Intensity D4-3___3,,,
RB2022_5_PreStrength,,,
NJH2024_Sub4_MICT_Mid,,,
TM2022_S2.4h.A,0.4673721892393564,,0.5281096288378808
RB2022_5_PostStrength,,,
GF2025_P6_Sph,0.3980244880732178,,0.49361286578285407
RB2022_2_PreSprint,,,
ZX2022_CB treated Replicate 3,,,
RM2024_Intensity D6-2___3,,,
WZ2023_Pe_025_10min,0.6229945128622286,0.5076153124216908,0.5957862332081283
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,,
AST2020_anti-CD3+PDL2.1,,,
KBE2022_Log2_Ex_34_U,,,
WZ2023_Pu_005_10min,0.6193759116369331,0.514140532210259,0.5950641425227123
AS2011_Ratio H/L RNAi_2_1,,,
NJH2024_Sub9_HIIT_Mid,,,
CK2022_9 40-1,,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,,
LG2023_GSK3α-1_intensity,,,
WZ2023_Pu_025_30min,0.6341269653970198,0.5007017513470053,0.5930696172785972
AH2018_SILAC_MR_2_X,,,
HS2024_4_PD_T2,0.4735925337720514,,0.5391492928831272
NJH2024_Sub4_HIIT_Pre,,,
RB2022_2_RecoverySprint,,,
AS2011_Ratio H/L Protein RNAi_1,,,
RM2024_Intensity D2-1___2,,,
CR2017_Ratio Replicate 1.4,0.5293259602825535,0.5260495531387344,0.5360420329163972
FR2021_Norm.Intensity.B,0.5044350063682326,,
RM2024_Intensity D6-2___1,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,,
RB2022_5_PostSprint,,,
EJN2021_3_Rest_Basal,,,
CR2017_Ratio Replicate 1.3,0.6269196357337583,0.5397971789169402,0.5298574254782233
AS2011_Ratio H/L Normalized by Protein RNAi_2,,,
KTGR2014_Ratio-Rapa 7 mins,,,
AMK2021_120R_p1,,,
AH2018_SILAC_3_X,,0.49097106051308054,
JJ2018_Ratio M/L normalized pP3,,,
AH2018_SILAC_M_2_N,,,
HS2024_7_PD_T2,0.6034508129181552,,0.5134090360558112
FSO2013_Ratio H/L normalized Rep1___1,0.5411645767951366,,0.48145337086801065
AH2018_LFQ_1_C,,0.48609661834640755,
AS2011_Ratio H/L Normalized Inhi_1_3,,,
KBE2022_Log2_Ex_28_T,,,
HS2024_3_B_N1,0.5417378389661296,,0.538953245062247
RM2024_Intensity D4-2___3,,,
WZ2023_Pe_025_30min,0.6228220465896149,0.4973251833805026,0.58997010380585
CK2022_11 40-1,,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,,
AH2018_SILAC_2_X,,,
MV2014_Ratio H/M normalized A2___2 (2 min),,,
AS2011_Ratio H/L RNAi_1_2,,,
KS2014_Intensity E15_1,,,
FSO2013_Ratio H/L normalized Rep2,0.4508437875360545,,0.4967350183555076
WZ2023_Pu_005_20min,0.634219417280293,0.4914840113161751,0.5899702268781988
NJH2024_Sub10_MICT_Post,,,
RM2024_Intensity D2-3___1,,,
CR2017_Ratio Replicate 1.5,0.4691205211743969,0.49945268222975037,0.5900577102248672
CW2012_10 µM Gef/control Experiment 2 Replicate B,,,
HS2024_7_B_T3,0.7004599627227603,,0.5132697006175202
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,0.587128757571786,,
AS2011_Ratio H/L RNAi_1,,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,,
AH2018_LFQ_M_1_C,,0.5038321600348633,
NJH2025_Sub7_MICT_Pre,,,
SR2019_SKBR3_Biol_repl_2,0.4005832650102162,,
HS2024_9_B_T2,0.5076709454117054,,0.48258407666990877
KTGR2014_Ratio-AA 7 mins,,,
MV2014_Ratio L/H normalized B3___3 (5 min),,,
HS2024_3_PD_T1,0.4204654690060063,,0.520155664917114
FSO2013_Ratio M/L normalized Rep3___2,,,
SR2019_BT549_Biol_repl_3,,,
RCJD2014_20min_mean,,,
FR2021_Norm.Intensity.H,0.5054089916251276,,
RB2022_2_PreStrength,,,
DB2022_LFQ intensity L1.2,,,
HS2024_4_B_N1,0.4809918947984059,,0.5085664767365173
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,,
CK2022_1 16-1,,,
CK2022_1 200-1,0.4967399833009861,,0.5177025452543436
PG2020_Intensity Mock_10h_D,,,
SR2019_MCF10A_Biol_repl_2,,,
JJ2018_Ratio M/L normalized pP2___2,,,
HS2024_6_PD_T1,0.5813650875897041,,0.461426020737169
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,,
RB2022_6_RecoveryEndurance,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,,
EP2017_Mitotic R#2 normalized log2 ratio,,,
RCJD2014_5min_1,,,
RM2024_Intensity D4-1___1,,,
DL2023_24h-1,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,,
TM2022_S2.4h.C,0.4374152278624381,,0.5261329059449791
SAS2015_PLX/AZD_Exp2,,,
CR2017_Ratio Replicate 3.3,0.5206288819259621,0.5111574633244771,0.5154087300168052
PG2020_Intensity 2h_C,,,
VOI2024_Veh2 di,,,
ZX2022_CB treated Replicate 2,,,
KBE2022_Log2_Ex_8_T,,,
NJH2025_Sub10_MICT_Post,,,
HS2024_6_I_T3,0.4916060123048431,,0.5061986281070011
RN2012_L11,,,
AS2011_Ratio H/L Normalized Inhi_2_2,,,
IMM2018_normalised rep. int. Empty-1,,,
HS2024_5_PD_T1,0.4719378853748848,,0.4550076373359706
AH2018_LFQ_M_2_C,,,
CK2022_3 40-1,,,
RBK2021_1260T Early,,,
NJH2024_Sub4_HIIT_Post,,,
HS2024_4_I_T1,0.607115611262449,,0.5449582501273545
YA2020_Reporter_intensity_Cancer_No.5,,,
HH2022_Reporter intensity 8,,,
ZQ2022_N2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,,
FSO2013_Ratio H/L normalized Rep3___3,,,
AH2018_TMTMS3_2_N,,,
EJN2021_5_Rest_Basal,,,
NJH2025_Sub2_HIIT_Post,,,
NJH2025_Sub1_MICT_Post,,,
HS2024_9_B_T1,0.48760740604066,,0.4936477548237523
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,,
JAW2011_Ratio H/L LS2_1,,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,,
NJH2024_Sub6_HIIT_Pre,,,
AH2018_SILAC_3_N,,0.4989588855772621,
YA2020_Reporter_intensity_Normal_No.1,,,
HS2024_3_B_T1,0.45534005482659,,0.5352196230769058
JJ2018_Ratio H/L normalized___2,,,
RM2024_Intensity D0-2,,,
MV2014_Ratio M/L normalized B1___2 (5 min),,,
RB2022_7_PostStrength,,,
RB2022_1_PostEndurance,,,
CR2017_Ratio Replicate 3,,0.5079101845919819,0.5243339748325202
SR2019_Hs578T_Biol_repl_3,,,
MV2014_Ratio L/H normalized B3___1 (5 min),,,
RBK2021_1244T Early,,,
RB2022_3_PostSprint,,,
NJH2024_Sub13_MICT_Mid,,,
KTGR2014_Ratio-AA 2 mins,,,
GF2025_P7_Sph,0.4349313849683714,,0.5549001243800369
HS2024_8_I_T3,0.5452818616272969,,0.5043167616139013
CF2017_EOC 3,,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,,
HS2024_6_PD_T3,0.3905183634542103,,0.4596187175829803
DL2023_12h-2,,,
RM2024_Intensity D6-3___1,,,
FS2019_Ctr1,,,
WZ2023_Pu_010_20min,0.6262385407574758,0.5080589455732996,0.5936876192216427
AS2011_Ratio H/L_3,,,
CK2022_1 40-1,,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,,
CK2022_8 16-1,,,
KS2014_Intensity N3,,,
RB2022_4_RecoveryEndurance,,,
RB2022_5_RecoveryEndurance,,,
JAW2011_Ratio H/L LS1a_2,,,
NJH2024_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_N,,,
FSO2013_Ratio H/M normalized Rep2,0.3714220752582845,,0.4597313638600586
RAM2015_Log2 A,0.5344127823671025,,0.5363295755244235
HS2024_8_PD_T1,0.5052299916924465,,0.5406551870173368
JJ2018_Ratio H/L normalized pP2,,,
CF2017_OSE 27,0.4191609016085962,,
KS2014_Intensity E15_2,,,
BS2014_Log2(Ratio H/L protein),,,
PG2020_Intensity 8h_A,,,
HS2024_7_I_T1,0.7368256230915594,,0.49091840996854075
VOI2024_Veh3 di,,,
RKK2015_TNF-α+SC-514/basal,,,0.5896181488177681
SR2019_JIMT1_Biol_repl_1,,,
HW2015_Ratio H/L normalized Exp2,,,
HS2024_3_I_N1,0.5669862105224036,,0.570141239465781
AH2018_SILAC_M_3_X,,0.4931885756221046,
NJH2024_Sub9_HIIT_Post,,,
AS2011_Ratio H/L RNAi_1_3,,,
GRW2016_Ratio H/L normalized SILAC 1___2,,,
NJH2025_Sub1_HIIT_Pre,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,,
NJH2024_Sub4_HIIT_Mid,,,
VOI2024_0.1uM 2 h_1 di,,,
KBE2022_Log2_Ex_6_T,,,
RM2024_Intensity D4-3___1,,,
AH2018_LFQ_4_X,,,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
RB2022_8_PostEndurance,,,
NJH2025_Sub4_MICT_Mid,,,
YP2020_Intensity C30_R1_mult_log2,,,
AST2020_anti-CD3.1,,,
NJH2025_Sub4_HIIT_Post,,,
EP2017_Untreated R#4 log2 ratio,,,
HS2024_6_B_N1,0.4727099868066073,,0.5315025656262884
KBE2022_Log2_Ex_27_T,,,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,,
VOI2024_0.1uM 24 h_1 mono,,,
AMK2021_120R_p5,,,
AS2011_Ratio H/L Proteins,,,
NJH2024_Sub7_HIIT_Post,,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,,
AS2011_Ratio H/L RNAi_2_2,,,
RB2022_7_RecoveryStrength,,,
AH2018_SILAC_IT_3_X,,0.5319849190381454,
JAW2011_Ratio H/L,,,
PG2020_Intensity 10h_C,,,
FSO2013_Ratio M/L normalized Rep2,0.4189046997059881,,0.4860029866922512
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,,
HH2022_Reporter intensity 5,,,
SR2019_HCC1954_Biol_repl_2,,,
CK2022_14 40-1,,,
RB2022_6_PreSprint,,,
NJH2025_Sub12_MICT_Mid,,,
PG2020_Intensity 4h_D,,,
NJH2025_Sub2_MICT_Post,,,
AH2018_LFQ_4_C,,,
DL2023_control-1,,,
AR2021_ALG 10 μM,,,
JAW2011_Ratio H/L LS2_2,,,
AH2018_SILAC_IT_3_N,,0.4873166901971602,
EJN2021_4_Rest_Ins,,,
RN2012_H05,0.5056926503421364,,
NJH2024_Sub7_HIIT_Mid,,,
GF2025_P2_Adh,0.5464173170009072,,0.5199250276334256
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,,
RB2022_8_PostSprint,,,
EJN2021_1_Rest_Ins,,,
HH2022_Reporter intensity 3,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,,
AH2018_SILAC_IT_1_C,,,
JW2021_After_3,,,
GF2025_P8_Sph,0.4181506024822268,,0.5430482091630818
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,,
JJ2018_Ratio M/L normalized pP2___1,,,
AH2018_SILAC_2_N,,,
CK2022_11 200-1,0.3887535683441644,,0.517958827752983
CK2022_12 200-1,0.405379375249869,,0.5195799556485177
AS2011_Ratio H/L Normalized by Protein RNAi_1,,,
RM2024_Intensity D2-1___3,,,
NJH2024_Sub1_MICT_Pre,,,
HH2022_Reporter intensity 9,,,
WZ2023_Su_010_20min,0.621323961763047,0.49180395977374947,0.5895194872686933
AH2018_TMTMS2_2_N,,,
NJH2024_Sub13_MICT_Pre,,,
KBE2022_Log2_Ex_41_U,,,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,,
AH2018_TMTMS3_Pool,,,
KS2014_Intensity N4,,,
NJH2024_Sub1_HIIT_Post,,,
MM2018_Ratio H/L replicate2,,,
RM2024_Intensity D4-2___2,,,
NJH2024_Sub13_HIIT_Pre,,,
CF2017_OSE 26,0.4021430856468326,,
CK2022_14 200-1,0.4176817615836973,,0.5394803476576031
SR2019_Hs578T_Biol_repl_1,,,
RB2022_7_PostSprint,,,
TM2022_mock.4h.A,0.390473443190021,,0.5034071355598049
NJH2025_Sub12_HIIT_Pre,,,
AH2018_TMTMS3_1_N,,,
AST2020_anti-CD3+PDL2.2,,,
PG2020_Intensity Mock_10h_A,,,
JW2021_After_2,,,
NJH2024_Sub2_MICT_Post,,,
EJN2021_2_Rest_Ins,,,
SR2019_LM2_Biol_repl_4,,,
CP2009_Ratio H/M,,,
JAW2011_Ratio H/L HS,,,
CK2022_13 16-1,,,
GF2025_P1_Adh,0.6092636786373413,,0.5065421435578742
GF2025_P1_Sph,0.4770088624357075,,0.531969123639336
EJN2021_5_Ex_Basal,,,
HS2024_7_I_T3,0.4858445282006403,,0.4983683384368638
JJ2018_Ratio H/L normalized pP2___2,,,
WZ2023_Pe_010_10min,0.6086075809242011,0.50338542605049,0.5849152206028787
CF2017_EOC 1,0.3956811481014035,,
CK2022_3 200-1,0.4908049309282918,,0.5144743650691921
AH2018_LFQ_IT_3_C,,,
SR2019_Hs578T_Biol_repl_2,,,
NJH2024_Sub12_HIIT_Post,,,
JJ2018_Ratio H/L normalized pP1___2,,,
MV2014_Ratio H/L normalized A1___2 (10 min),,,
NJH2024_Sub10_MICT_Mid,,,
NJH2024_Sub13_MICT_Post,,,
BS2014_Log2(Ratio H/L normalized Rep_1),0.3639955134192748,,0.40407260443248577
RB2022_3_RecoverySprint,,,
NJH2025_Sub1_HIIT_Mid,,,
RCJD2014_20min_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,,
HS2024_6_PD_T2,0.6216457192909061,,0.43208749144727393
HS2024_5_B_T1,0.7372008699934175,,0.6541569141609955
CW2012_10 µM Gef/control Experiment 2 Replicate A,,,
DL2023_12h-3,,,
SR2019_MDAMB231_Biol_repl_2,,,
HS2024_3_B_T2,0.5663116905957026,,0.5645916119848338
RB2022_6_PreStrength,,,
CK2022_2 40-1,,,
RB2022_1_PostSprint,,,
CK2022_4 200-1,0.4946574555128911,,0.5179606180500951
JW2021_Before_2,,,
TM2022_S2.12h.A,0.4364760633379448,,0.5264935199320475
MV2014_Ratio L/M normalized B2___2 (30 min),,,
CK2022_5 16-1,,,
AR2021_ALG 1 μM,,,
HS2024_4_B_T1,0.6124822832335618,,0.5431215595382308
MV2014_Ratio M/H normalized A3___1 (10 min),,,
SR2019_BT549_Biol_repl_4,,,
EJN2021_1_Rest_Basal,,,
NJH2025_Sub8_MICT_Post,,,
RCJD2014_5min_3,,,
CR2017_Ratio Replicate 3.2,0.4473487183165619,0.4761383663717505,0.49256857509086205
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,,
GF2025_P7_Adh,0.5654258181922225,,0.5373314891310288
CK2022_9 16-1,,,
NJH2024_Sub6_HIIT_Post,,,
AMK2021_30R_p3,,,
AS2011_Ratio H/L Normalized RNAi_2,,,
RM2024_Intensity D0-2___2,,,
KS2014_Intensity pY_N4,,,
CK2022_13 200-1,0.4128405787068139,,0.5397993230821423
AS2011_Ratio H/L Normalized_2,,,
PG2020_Intensity 6h_D,,,
CK2022_16 16-1,,,
FS2019_db/db3,,,
CK2022_15 40-1,,,
NJH2024_Sub9_MICT_Pre,,,
BS2014_Log2(Ratio H/L unmodified peptide),,,
WZ2023_Su_005_10min,0.6281656507142916,0.49002060279100573,0.5929581671352986
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,,
KBE2022_Log2_Ex_41_T,,,
AMK2021_Ctrl_p1,,,
AH2018_LFQ_IT_3_X,,,
HS2024_5_PD_T3,0.4487890917632982,,0.4811055542524872
AH2018_TMTMS3_3_X,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,,
KBE2022_Log2_Ex_40_U,,,
AH2018_LFQ_M_1_N,,0.5265760997841746,
KBE2022_Log2_Ex_27_U,,,
HW2015_Ratio M/L normalized Exp3,,,
RKK2015_TNF-α/IKKb(K44M),0.6695789734569576,,0.7004293631856047
AH2018_SILAC_M_1_N,,,
HW2015_Ratio M/L normalized Exp1,,,
RB2022_5_RecoveryStrength,,,
YP2020_Intensity P10_R1_mult_log2,,,
RB2022_7_PreStrength,,,
YA2020_Reporter_intensity_Normal_No.4,,,
NJH2025_Sub13_HIIT_Pre,,,
PG2020_Intensity CT_D,0.3482202855809524,,
NJH2025_Sub9_MICT_Post,,,
VOI2024_Veh1 mono,,,
CK2022_12 16-1,,,
RN2012_L13,0.5717755964236557,,
LG2023_Control-1_intensity,,,
RM2024_Intensity D6-3___2,,,
KBE2022_Log2_Ex_8_U,,,
SR2019_SKBR3_Biol_repl_3,0.2964179341974399,,
NJH2024_Sub1_MICT_Post,,,
HS2024_3_I_T2,0.4758123128295639,,0.533492802953009
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,,
RM2024_Intensity D0-3___3,,,
HS2024_6_I_T2,0.5093828064737137,,0.5103749173844222
CW2012_10 µM Erl/control Experiment 2 Replicate B,,,
AS2011_Ratio H/L Protein Inhi_1,,,
FSO2013_Ratio H/M normalized Rep2___1,0.3920753482408272,,0.4694171907119897
GRW2016_Ratio M/L normalized SILAC 5a___2,,,
CK2022_10 40-1,,,
NJH2024_Sub12_HIIT_Pre,,,
NJH2024_Sub8_MICT_Pre,,,
RM2024_Intensity D0-1___1,,,
LY2019_P3+,0.4399297498631856,,0.5095341643584195
HH2022_Reporter intensity 6,,,
RB2022_2_RecoveryStrength,,,
KTGR2014_Ratio-AA 15 mins,,,
AS2011_Ratio H/L Normalized RNAi_2_2,,,
KS2014_Intensity pY_N3,,,
MV2014_Ratio H/L normalized B1___2 (30 min),,,
LY2019_P5-,,,
HW2015_Ratio M/L normalized Exp2,,,
SR2019_HCC1419_Biol_repl_1,0.3921386613125469,,
AH2018_TMTMS2_3_X,,,
GF2025_P3_Adh,0.6618815021240523,,0.5459259963095873
SR2019_JIMT1_Biol_repl_2,0.3949431720892918,,
AH2018_TMTMS2_1_C,,,
RM2024_Intensity D0-1___2,,,
LY2019_P4+,0.6160220367941138,,0.6133819214941654
KBE2022_Log2_Ex_19_U,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,0.5815459866852604,,
RB2022_4_PostStrength,,,
LG2023_GSK3α-3_intensity,,,
YA2020_Reporter_intensity_Cancer_No.1,,,
AST2020_Control,,,
JAW2011_Ratio H/L LS1a,,,
RCJD2014_5min_mean,,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,,
NJH2025_Sub1_MICT_Mid,,,
TM2022_S2.12h.C,0.4437297245381181,,0.5293613094873093
NJH2025_Sub9_MICT_Mid,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,0.6248370541487208,,
AS2011_Ratio H/L Normalized Inhi_1_2,,,
FSO2013_Ratio M/L normalized Rep2___1,0.4206859514165378,,0.4870906909198952
LG2023_Control-2_intensity,,,
NJH2024_Sub8_HIIT_Pre,,,
KS2014_Intensity pY_N2,,,
RB2022_5_RecoverySprint,,,
RB2022_7_RecoverySprint,,,
YA2020_Reporter_intensity_Normal_No.3,,,
HS2024_8_B_T2,0.4695378305026708,,0.5257787453519329
AH2018_LFQ_1_X,,0.48218170810237426,
RM2024_Intensity D6-1___1,,,
RCJD2014_10min_2,,,
FR2021_Norm.Intensity.M,0.4752439940698,,
RM2024_Intensity D0-3___1,,,
KS2014_Intensity N2,,,
HH2022_Reporter intensity 1,,,
HH2022_Reporter intensity 2,,,
RM2024_Intensity D6-2___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,,
RM2024_Intensity D2-3___2,,,
YA2020_Reporter_intensity_Normal_No.5,,,
SR2019_MCF7_Biol_repl_1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,,
HS2024_8_B_T1,0.3864899303568336,,0.4509200544805415
NJH2025_Sub6_HIIT_Pre,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,,
EP2017_Untreated R#2 log2 ratio,,,
SR2019_LM2_Biol_repl_3,,,
RB2022_4_RecoveryStrength,,,
CR2017_Ratio Replicate 2,0.4558698219837436,,0.555620661310867
CW2012_10 µM Erl/control Experiment 2 Replicate A,,,
FSO2013_Ratio H/M normalized Rep3,0.345154956748071,,0.5278770644736337
AR2021_KD 72h,,,
MV2014_Ratio H/M normalized B2___3 (5 min),,,
KBE2022_Log2_Ex_18_U,,,
AS2011_Ratio H/L Inhi_1_1,,,
NJH2024_Sub8_MICT_Post,,,
AH2018_TMTMS3_3_C,,,
KBE2022_Log2_Ex_9_U,,,
AH2018_SILAC_M_3_N,,0.5008601447356889,
KBE2022_Log2_Ex_13_T,,,
RM2024_Intensity D0-3,,,
SR2019_SKBR3_Biol_repl_1,0.3375341575563588,,
PG2020_Intensity Mock_10h_C,,,0.41191697078056255
CF2017_OSE 29,,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,,
NJH2025_Sub1_HIIT_Post,,,
DL2023_24h-2,,,
HS2024_7_B_N2,0.5205257116820505,,0.4873683106387098
PG2020_Intensity 10h_A,,,
RN2012_L12,,,
MV2014_Ratio M/L normalized B1___3 (5 min),,,
NJH2024_Sub8_MICT_Mid,,,
AH2018_LFQ_IT_4_C,,0.49656674926831845,
SAS2015_PLX/AZD_Exp1,,,
FR2021_Norm.Intensity.A,0.4536104755919322,,
FSO2013_Ratio H/M normalized Rep1___1,0.5814675928880779,,0.4692939812897663
JW2015_Intensity cap2,,,
BS2014_Log2(Ratio H/L normalized Rep_2),0.3814072890009682,,0.4120798631286775
NJH2024_Sub6_MICT_Post,,,
CK2022_8 40-1,,,
RB2022_7_RecoveryEndurance,,,
NJH2025_Sub12_HIIT_Post,,,
EJN2021_4_Ex_Basal,,,
TM2022_S2.12h.B,0.4095487293649497,,0.5139785955166203
RN2012_L15,,,
KS2014_Intensity pY_PV3,,,
TM2022_S2.4h.B,0.5017983633030337,,0.5237574037595583
PG2020_Intensity 4h_A,,,
FSO2013_Ratio H/M normalized Rep2___2,,,
TM2022_mock.4h.B,0.4596597724869862,,0.5349875287397353
KBE2022_Log2_Ex_24_U,,,
NJH2025_Sub13_MICT_Mid,,,
KS2014_Intensity C3,,,
RB2022_1_PreSprint,,,
HS2024_4_I_N1,0.5763141310741021,,0.5743278762941815
CK2022_7 200-1,0.3939471566387709,,0.5267815844223351
CK2022_5 200-1,0.4125288743437386,,0.5190575908644148
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,0.5670669710212584,,
FSO2013_Ratio H/L normalized Rep2___1,0.4520435369405048,,0.4974808286325686
NJH2024_Sub10_HIIT_Mid,,,
RB2022_2_PostEndurance,,,
AH2018_LFQ_2_C,,,
AH2018_SILAC_MR_1_X,,,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,,
IMM2018_normalised rep. int. Empty-2,,,
RM2024_Intensity D4-1,,,
KBE2022_Log2_Ex_25_U,,,
AH2018_SILAC_3_C,,0.4966389855178947,
EJN2021_5_Rest_Ins,,,
VOI2024_0.1uM 24 h_3 di,,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,,
DB2022_LFQ intensity L2.1,,,
FSO2013_Ratio H/M normalized Rep1,0.5740292430347108,,0.4621755799485848
CK2022_4 16-1,,,
AS2011_Ratio H/L,,,
SR2019_MCF7_Biol_repl_4,0.3815836734505817,,
EJN2021_2_Ex_Ins,,,
AS2011_Ratio H/L Inhi_2_3,,,
JAW2011_Ratio H/L LS1a_1,,,
AH2018_LFQ_1_N,,0.514851378032541,
SAS2015_PLX/DMSO_Exp1,,,
SFR2015_HL_log2_ratio_avg_c,,,
JJ2018_Ratio M/L normalized pP2,,,
NJH2024_Sub7_MICT_Mid,,,
PG2020_Intensity 6h_B,,,
FSO2013_Ratio H/L normalized Rep3,0.4469631068687955,,0.5301492585841467
GRW2016_Ratio H/L normalized SILAC 2___2,,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,0.5690424810663678,,0.38215786047567396
JJ2018_Ratio M/L normalized,,,
KTGR2014_Ratio-AA 30 mins,,,
JW2021_After_1,,,
NJH2025_Sub2_MICT_Mid,,,
HS2024_6_B_N2,0.447826067010614,,0.48483003214380815
KBE2022_Log2_Ex_9_T,,,
AH2018_SILAC_IT_2_N,,0.4800256407414535,
AH2018_SILAC_IT_1_X,,0.5314432472657352,
HW2015_Ratio H/L normalized Exp3,,,
HS2024_7_PD_T1,0.6063118233155226,,0.541697573418342
UK2020_UA_2,,,
RM2024_Intensity D2-1___1,,,
GF2025_P10_Sph,0.5413280820401154,,0.4833942448434485
WZ2023_Pe_025_20min,0.6244003727594848,0.48738250964085084,0.5925811578256286
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,,
AH2018_LFQ_2_N,,0.49424431607796,
HS2024_4_I_N2,0.6830347042742084,,0.5755387886923315
AH2018_TMTMS2_3_N,,,
RN2012_H06,,,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
HS2024_4_PD_T3,0.4868565099180763,,0.5328887009114633
WZ2023_Su_005_30min,0.6254568608169442,0.5043938327157509,0.5929519787644266
SR2019_HCC1419_Biol_repl_4,0.3765010895188234,,
JJ2018_Ratio H/M normalized___2,,,
SR2019_JIMT1_Biol_repl_3,0.4083234601996304,,
AS2011_Ratio H/L Protein,,,
UK2020_HCM_3,,,
NJH2024_Sub10_HIIT_Post,,,
CR2017_Ratio Replicate 3.1,,0.5295048951624608,0.4915412577285083
WZ2023_Su_025_10min,0.6261612349362933,0.49931336475412663,0.5956091326132782
AH2018_LFQ_IT_4_X,,0.4908968041536101,
CP2009_Ratio H/L,,,
VOI2024_0.1uM 24 h_3 mono,,,
RB2022_4_RecoverySprint,,,
RM2024_Intensity D6-3,,,
WZ2023_Su_005_20min,0.6289369519951922,0.4884889748752479,0.5946509414494381
CW2012_10 µM Gef/control Experiment 1 Replicate B,,,
SFR2015_HL_log2_ratio_avg_a,,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,,
RB2022_1_PreEndurance,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,,
LG2023_GSK3α-2_intensity,,,
EP2017_Pervanadate R#1 log2 ratio,,,
NJH2025_Sub6_HIIT_Post,,,
RB2022_6_RecoverySprint,,,
KS2014_Intensity,,,
MV2014_Ratio H/M normalized A2___1 (2 min),,,
PG2020_Intensity 8h_D,,,
LY2019_P7+,,,0.47200505699027867
EP2017_Untreated R#1 normalized log2 ratio,,,
RN2012_L10,,,
PG2020_Intensity 4h_C,,,
EP2017_Mitotic R#3 normalized log2 ratio,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,,
DB2022_LFQ intensity L1,,,
KBE2022_Log2_Ex_24_T,,,
RB2022_8_PostStrength,,,
AH2018_SILAC_IT_2_X,,0.5317139208299171,
HS2024_4_B_T3,0.603251560278153,,0.5500211425264785
NJH2024_Sub2_HIIT_Post,,,
HS2024_8_B_N2,0.6199382215724202,,0.5155688837926179
NJH2025_Sub8_HIIT_Pre,,,
JJ2018_Ratio H/L normalized pP2___1,,,
HS2024_8_I_T2,0.5724725799175523,,0.42225729171434817
KBE2022_Log2_Ex_6_U,,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,,
CR2017_Ratio Replicate 1.1,0.5995883685170161,0.5377535897439054,0.5564395700008914
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,0.606625837313856,,
MV2014_Ratio M/H normalized B3___2 (30 min),,,
CK2022_16 200-1,0.4272262634729175,,0.5389110912586816
VOI2024_0.1uM 2 h_3 di,,,
EP2017_Mitotic R#1 normalized log2 ratio,,,
GF2025_P9_Sph,0.4945023855321941,,0.5661204661868505
CK2022_6 200-1,0.3987854290966879,,0.5274158446992188
NJH2024_Sub7_MICT_Post,,,
AH2018_TMTMS3_2_X,,,
NJH2024_Sub8_HIIT_Post,,,
DB2022_LFQ intensity R1,,,
JW2015_Intensity cap3,,,
SR2019_HCC1954_Biol_repl_1,0.4267998999657472,,
HS2024_4_I_T2,0.5583811572532117,,0.5461860508257912
NJH2024_Sub2_MICT_Mid,,,
VOI2024_0.1uM 2 h_2 mono,,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,,
HS2024_4_PD_T1,0.4904156537466841,,0.5709541285289912
SAS2015_AZD/DMSO_Exp1,,,
NJH2024_Sub1_MICT_Mid,,,
IMM2018_normalised rep. int. CDK5L-3,,,
HS2024_3_B_T3,0.6860351691417708,,0.4916926669643689
MV2014_Ratio L/H normalized A3___2 (2 min),,,
NJH2025_Sub13_MICT_Pre,,,
SR2019_MDAMB231_Biol_repl_3,,,
GRW2016_Ratio H/L normalized SILAC 4___1,,,
MM2018_Ratio H/L replicate1,,,
PG2020_Intensity 2h_D,0.3413931727469078,,
EP2017_Untreated R#3 normalized log2 ratio,,,
MV2014_Ratio M/H normalized A3___3 (10 min),,,
NJH2024_Sub7_HIIT_Pre,,,
JAW2011_Ratio H/L LS2,,,
CK2022_8 200-1,0.3937522429786922,,0.5212521369093346
KS2014_Intensity pY_C4,,,
CR2017_Ratio Replicate 3.5,0.4290639651381579,0.4727976306709345,0.4828684918840603
RB2022_7_PostEndurance,,,
NJH2025_Sub4_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,,
TM2022_mock.12h.A,0.5014893421837687,,0.5480005753860537
JJ2018_Ratio H/L normalized pP1,,,
EP2017_Pervanadate R#2 normalized log2 ratio,,,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,,
KS2014_Intensity pY_E5_4,,,
RM2024_Intensity D4-3___2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,0.5239107301107088,,
AH2018_SILAC_2_C,,,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
HS2024_7_I_N1,0.4235668157028099,,0.5297190503452985
KBE2022_Log2_Ex_29_T,,,
HS2024_7_I_T2,0.5215215423709311,,0.497016070294789
AS2011_Ratio H/L Normalized RNAi_2_3,,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,,
HS2024_6_B_T2,0.5806091353819872,,0.5862560629329181
AMK2021_45I_p5,,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,,
SAS2015_PLX/DMSO_Exp2,,,
EJN2021_1_Ex_Basal,,,
FR2021_Intensity.M,0.4752439940698,,
RB2022_2_PostSprint,,,
AH2018_SILAC_MR_3_N,,,
MV2014_Ratio H/L normalized B1___3 (30 min),,,
CF2017_FTE 13,0.4754397105929523,,
PG2020_Intensity CT_C,,,
ZCP2016_Ratio H/L Rep 1,,,0.566126583411577
FS2019_db/db2,,,
KS2014_Intensity pY_PV4,,,
KBE2022_Log2_Ex_39_U,,,
EP2017_Untreated R#3 log2 ratio,,,
RB2022_2_PostStrength,,,
AS2011_Ratio H/L Normalized_1,,,
MV2014_Ratio M/H normalized A3___2 (10 min),,,
CR2017_Ratio Replicate 3.4,0.4411896908156,0.48863813703058545,0.50956695177577
HS2024_8_PD_T2,0.4504307745633821,,0.5007730029268354
FS2019_Ctr2,,,
RB2022_6_PreEndurance,,,
FR2021_Norm.Intensity.G,0.4785417612108621,,
NJH2025_Sub9_HIIT_Post,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,0.5536091535548587,,
RM2024_Intensity D4-3,,,
HS2024_8_B_N1,0.4704828756561605,,0.4465656576235895
NJH2025_Sub10_MICT_Mid,,,
KBE2022_Log2_Ex_15_U,,,
AS2011_Ratio H/L Normalized Inhi_2,,,
RKK2015_TNF-α/SC-514,0.5266001690387218,,0.35929830198532076
RB2022_3_PreSprint,,,
CR2017_Ratio Replicate 2.3,0.5134318548581945,0.4982625848934778,0.5288757843713721
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,,
GF2025_P4_Adh,0.5540668778673496,,0.5162412756227569
YA2020_Reporter_intensity_Normal_No.2,,,
YP2020_Intensity P30_R2_mult_log2,,,
NJH2025_Sub13_MICT_Post,,,
HS2024_4_B_N2,0.5662376610369095,,0.5145966924697434
HS2024_3_PD_T3,0.5235418013125798,,0.5552957384560417
AMK2021_120R_p3,,,
MV2014_Ratio L/H normalized A3___3 (2 min),,,
NJH2025_Sub10_HIIT_Pre,,,
FR2021_Intensity.G,0.4951202743823745,,
RAM2015_Log2 C,,,
AS2011_Ratio H/L Proteins Inhi_1,,,
FSO2013_Ratio H/M normalized Rep1___3,,,
AH2018_LFQ_M_2_N,,0.5104531403373653,
MV2014_Ratio M/L normalized A1___3 (2 min),,,
KBE2022_Log2_Ex_40_T,,,
CK2022_2 16-1,,,
RAM2015_Log2 B,0.5234128869836874,,0.5308296278327158
YP2020_Intensity C10_R1_mult_log2,,,
FSO2013_Ratio M/L normalized Rep1___2,,,
NJH2025_Sub8_MICT_Pre,,,
EJN2021_4_Rest_Basal,,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,,
JJ2018_Ratio H/M normalized pP3___1,,,
VOI2024_Veh2 mono,,,
HS2024_6_B_T1,0.5562723331863312,,0.5501231899492907
UK2020_HCM_5,,,
NJH2025_Sub10_HIIT_Post,,,
VOI2024_0.1uM 2 h_3 mono,,,
JW2015_Intensity pre3,,,
AS2011_Ratio H/L Normalized Inhi_2_1,,,
DL2023_24h-3,,,
HS2024_7_PD_T3,0.5437139546458795,,0.5240244657366906
PG2020_Intensity Mock_10h_B,0.3001783989382155,,
WZ2023_Su_025_30min,0.6207553164277133,0.5023467599165046,0.5886515617303655
AH2018_LFQ_4_N,,0.5133468875872289,
CR2017_Ratio Replicate 1.2,0.631474836876885,0.5135683414754482,0.5509135021293741
AS2011_Ratio H/L Normalized by Proteins,,,
RB2022_6_RecoveryStrength,,,
HS2024_8_I_N1,0.5427376718918456,,0.4604385644954433
AMK2021_Ctrl_p3,,,
AS2011_Ratio H/L Protein Inhi_2,,,
HH2022_Reporter intensity 7,,,
AH2018_SILAC_M_1_X,,,
RB2022_7_PreEndurance,,,
VOI2024_0.1uM 24 h_2 di,,,
DL2023_control-2,,,
LY2019_P6+,,,0.39307349038359884
DB2022_LFQ intensity R2,,,
GF2025_P6_Adh,0.4231905299152555,,0.5474987811747836
VOI2024_Veh1 di,,,
AS2011_Ratio H/L RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,,
VOI2024_Veh3 mono,,,
HS2024_5_I_T2,0.4875769521314723,,0.5552171939896711
NJH2025_Sub7_HIIT_Mid,,,
MV2014_Ratio H/L normalized B1___1 (30 min),,,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,,
RB2022_6_PostSprint,,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,,
AS2011_Ratio H/L Inhi_1,,,
AS2011_Ratio H/L Normalized RNAi_1_2,,,
AH2018_TMTMS3_2_C,,,
SR2019_Hs578T_Biol_repl_4,,,
RB2022_8_PreStrength,,,
KS2014_Intensity C5,,,
RM2024_Intensity D0-1,,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,,
YP2020_Intensity P30_R1_mult_log2,,,
NJH2025_Sub2_HIIT_Pre,,,
RB2022_3_RecoveryEndurance,,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,,
GF2025_P9_Adh,0.5232991349485021,,0.5808962100604562
RB2022_3_PostStrength,,,
TM2022_S2.8h.A,0.4555073773851162,,0.5272521064868483
AS2011_Ratio H/L RNAi_1_1,,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,,
NJH2025_Sub2_MICT_Pre,,,
MV2014_Ratio L/M normalized A2___3 (10 min),,,
MV2014_Ratio H/M normalized A2___3 (2 min),,,
HS2024_4_B_T2,0.6650596671921511,,0.5792143336396222
SR2019_BT549_Biol_repl_1,,,
AH2018_LFQ_M_4_N,,0.5271917276979217,
NJH2024_Sub8_HIIT_Mid,,,
PG2020_Intensity 8h_B,,,
AH2018_LFQ_2_X,,,
PG2020_Intensity 2h_B,,,
AS2011_Ratio H/L Proteins RNAi_1,,,
RB2022_4_PostSprint,,,
KS2014_Intensity E15_3,,,
GF2025_P3_Sph,0.4651073300829721,,0.5809013887262833
DB2022_LFQ intensity L2,,,
MV2014_Ratio H/L normalized A1___1 (10 min),,,
AH2018_SILAC_1_C,,,
NJH2024_Sub1_HIIT_Pre,,,
FSO2013_Ratio M/L normalized Rep2___2,,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,,
AS2011_Ratio H/L RNAi_2_3,,,
AH2018_SILAC_IT_1_N,,0.4861882070065527,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,,
RB2022_4_PreEndurance,,,
JJ2018_Ratio M/L normalized pP1,,,
CR2017_Ratio Replicate 2.4,0.4711972037487013,0.47017667566602844,0.4950201465651642
ZQ2022_N1,,,
LY2019_P6-,,,0.4878515851995806
RM2024_Intensity D2-3,,,
UK2020_HCM_1,,,
JW2015_Intensity pre2,,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,,
RM2024_Intensity D2-1,,,
NJH2025_Sub12_MICT_Post,,,
MV2014_Ratio H/M normalized B2___2 (5 min),,,
RN2012_L14,,,
AH2018_LFQ_3_N,,0.49827669824691656,
RKK2015_TNF-α/IKKb,0.6282060668418531,,0.7080883982829688
SFR2015_HL_log2_ratio_std_b,,,
UK2020_UA_1,,,
KBE2022_Log2_Ex_13_U,,,
AS2011_Ratio H/L Normalized Inhi_1,,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,,
RB2022_1_RecoverySprint,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,0.6605673836366842,,
JJ2018_Ratio H/L normalized pP3,,,
CK2022_7 40-1,,,
AS2011_Ratio H/L Inhi_1_3,,,
NJH2025_Sub10_HIIT_Mid,,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,,
JAW2011_Ratio H/L LS1b_1,,,
PG2020_Intensity 4h_B,,,
SR2019_BT549_Biol_repl_2,,,
RM2024_Intensity D4-2,,,
DB2022_LFQ intensity R2.2,,,
JJ2018_Ratio H/L normalized,,,
RB2022_5_PostEndurance,,,
HS2024_5_PD_T2,0.3967639543255511,,0.47738418499423957
WZ2023_Su_025_20min,0.6298967880376475,0.49264266088225395,0.596330290827723
RM2024_Intensity D2-2___1,,,
IMM2018_normalised rep. int. CDK5L-2,,,
LY2019_P8-,,,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,0.5675828123719915,,
FSO2013_Ratio H/L normalized Rep1,0.5283626389614097,,0.47333371319435225
NJH2024_Sub2_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,0.6464540979658039,,
CK2022_13 40-1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,,
RN2012_H02,,,
PG2020_Intensity 10h_D,,,
RB2022_8_PreEndurance,,,
HS2024_3_B_N2,0.5312662103375022,,0.5465619225775635
EJN2021_4_Ex_Ins,,,
AS2011_Ratio H/L Normalized by Protein,,,
EJN2021_1_Ex_Ins,,,
EP2017_Pervanadate R#3 log2 ratio,,,
FSO2013_Ratio M/L normalized Rep1___3,,,
NJH2025_Sub4_HIIT_Mid,,,
RCJD2014_5min_2,,,
RB2022_6_PostStrength,,,
AH2018_SILAC_MR_3_C,,,
AH2018_LFQ_M_4_C,,,
NJH2024_Sub4_MICT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_1_1,,,
DL2023_12h-1,,,
MV2014_Ratio L/M normalized B2___1 (30 min),,,
DB2022_LFQ intensity L1.1,,,
NJH2025_Sub6_MICT_Pre,,,
NJH2025_Sub6_MICT_Post,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,0.5950280140872461,,
RN2012_H04,0.4679032471038648,,
CK2022_6 40-1,,,
DB2022_LFQ intensity R2.1,,,
KBE2022_Log2_Ex_42_U,,,
LY2019_P3-,0.8313757295128658,,0.5019268286097669
FR2021_Intensity.A,0.4381309156621814,,
EJN2021_3_Ex_Ins,,,
MV2014_Ratio M/L normalized A1___1 (2 min),,,
WZ2023_Pe_005_30min,0.6085201831635357,0.5019824579482706,0.5858908992225187
HS2024_8_PD_T3,0.4515835851300825,,0.5580272249062426
EJN2021_3_Ex_Basal,,,
AST2020_Control.1,,,
JW2015_Intensity cap1,,,
PG2020_Intensity CT_A,,,
FS2019_Ctr3,,,
WZ2023_Pu_025_20min,0.6273707420527785,0.5015304841231605,0.591936236777779
NJH2025_Sub4_MICT_Post,,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,,
GF2025_P10_Adh,0.502066212347132,,0.5133121538885945
RB2022_1_RecoveryStrength,,,
SR2019_HCC1954_Biol_repl_4,,,
FR2021_Norm.Intensity.N,0.4911413893863205,,
HS2024_5_B_N1,0.4675569134631905,,0.5183746453931872
FSO2013_Ratio H/M normalized Rep3___3,,,
AH2018_TMTMS2_2_C,,,
RB2022_4_PreSprint,,,
DB2022_Intensity R2,,,
AH2018_TMTMS2_Pool,,,
HS2024_8_I_N2,0.5095235231770092,,0.44818044216401254
RB2022_3_RecoveryStrength,,,
NJH2024_Sub6_HIIT_Mid,,,
AH2018_SILAC_M_1_C,,,
LY2019_P8+,,,0.5964615297007239
RB2022_2_RecoveryEndurance,,,
JJ2018_Ratio H/M normalized pP2___1,,,
JAW2011_Ratio H/L HS_1,,,
RB2022_3_PostEndurance,,,
KS2014_Intensity pY_PV1,,,
JAW2011_Ratio H/L LS1b_2,,,
SR2019_MCF7_Biol_repl_2,0.376797945691028,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,,
AS2011_Ratio H/L Normalized RNAi_1_1,,,
AH2018_LFQ_M_4_X,,,
NJH2024_Sub6_MICT_Pre,,,
JJ2018_Ratio M/L normalized pP1___2,,,
YP2020_Intensity C30_R2_mult_log2,,,
NJH2024_Sub9_HIIT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_2_3,,,
RM2024_Intensity D0-1___3,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,,
KBE2022_Log2_Ex_28_U,,,
GRW2016_Ratio H/L normalized SILAC 1___1,,,
CF2017_FTE 17,0.356937413343606,,
LY2019_P2-,0.390873245081405,,0.47206214543786174
AH2018_LFQ_IT_1_X,,,
JJ2018_Ratio H/L normalized pP3___1,,,
RB2022_8_RecoveryStrength,,,
WZ2023_Pe_005_20min,0.6204608303906715,0.5030567790657244,0.5926538007328493
AST2020_Control.2,,,
NJH2025_Sub6_MICT_Mid,,,
RCJD2014_10min_1,,,
FSO2013_Ratio H/L normalized Rep2___3,,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,,
HS2024_3_I_T1,0.3665741344653679,,0.5306064545117972
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,,
CK2022_4 40-1,,,
SR2019_MCF10A_Biol_repl_4,,,
KS2014_Intensity pY_C5,,,
NJH2025_Sub4_MICT_Pre,,,
NJH2024_Sub9_MICT_Post,,,
CF2017_OSE 28,,,
HS2024_5_B_T2,0.5889960439894504,,0.5992189434222925
HS2024_6_I_T1,0.5195346358112164,,0.5334302337069474
HS2024_5_B_T3,0.4813123578736399,,0.5105574198117717
JJ2018_Ratio H/M normalized pP1___1,,,
KBE2022_Log2_Ex_36_U,,,
AH2018_TMTMS3_3_N,,,
SR2019_HCC1419_Biol_repl_2,0.3190268038138185,,
FR2021_Intensity.N,0.491026278952026,,
AS2011_Ratio H/L Inhi_2_1,,,
AH2018_SILAC_MR_1_C,,,
NJH2024_Sub1_HIIT_Mid,,,
NJH2025_Sub8_HIIT_Mid,,,
EP2017_Mitotic R#3 log2 ratio,,,
KBE2022_Log2_Ex_36_T,,,
NJH2025_Sub6_HIIT_Mid,,,
WZ2023_Pu_005_30min,0.6293473050303502,0.5096195376100143,0.5971825827168105
KS2014_Intensity C2,,,
FSO2013_Ratio H/L normalized Rep1___2,,,
RM2024_Intensity D2-2,,,
KBE2022_Log2_Ex_42_T,,,
CK2022_9 200-1,0.37753987075208,,0.5175427433507689
GRW2016_Ratio H/L normalized SILAC 2___1,,,
JJ2018_Ratio H/M normalized pP3___2,,,
DB2022_LFQ intensity R1.1,,,
CK2022_10 200-1,0.3750990550952602,,0.5113555668051607
NJH2024_Sub9_MICT_Mid,,,
JAW2011_Ratio H/L_2,,,
HS2024_7_I_N2,0.5243125796196878,,0.55732577798566
RBK2021_1332T Late,,,
LY2019_P1-,0.5744431872825133,,
RKK2015_TNF-α/basal.1,,,0.6643168154515353
RKK2015_TNF-α/TNF-α+SC-514,,,0.6347265937901698
CR2017_Ratio Replicate 2.5,0.4374397398362311,0.624896326752781,0.48202493797613033
HS2024_3_I_T3,0.4395195075355644,,0.503516791659188
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,0.5717157633273088,,
AS2011_Ratio H/L Normalized RNAi_1,,,
KS2014_Intensity E15_4,,,
ZQ2022_C3,,,
EJN2021_3_Rest_Ins,,,
YP2020_Intensity P10_R2_mult_log2,,,
MV2014_Ratio H/L normalized A1___3 (10 min),,,
NJH2025_Sub1_MICT_Pre,,,
KBE2022_Log2_Ex_39_T,,,
FSO2013_Ratio H/M normalized Rep3___2,,,
RM2024_Intensity D6-2,,,
EP2017_Untreated R#1 log2 ratio,,,
RKK2015_SC-514/basal,0.6129229077128019,,0.7397498680481973
RM2024_Intensity D6-1___3,,,
WZ2023_Pu_010_10min,0.6335764563468924,0.49405095890940876,0.5839062889344486
NJH2025_Sub9_HIIT_Mid,,,
SR2019_SKBR3_Biol_repl_4,0.3802139440655421,,
HS2024_5_I_T3,0.4594456539781058,,0.5253935044375957
KS2014_Intensity N1,,,
NJH2024_Sub12_MICT_Post,,,
TM2022_S2.8h.C,0.4430397622598568,,0.5308199713820924
CR2017_Ratio Replicate 1,0.6219690108529025,0.5284078147087778,0.49249096580960805
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,0.5542267192543756,,
JJ2018_Ratio H/M normalized pP3,,,
AH2018_SILAC_MR_2_C,,,
LATM2013_Log2 Ratio (Medium/Light) Forward,,,
PG2020_Intensity 2h_A,,,
NJH2024_Sub6_MICT_Mid,,,
NJH2025_Sub13_HIIT_Post,,,
AH2018_SILAC_MR_3_X,,,
JJ2018_Ratio H/M normalized___1,,,
RCJD2014_15min_2,,,
AS2011_Ratio H/L_2,,,
AS2011_Ratio H/L Normalized,,,
RN2012_H03,,,
HS2024_5_B_N2,0.4945250584959492,,0.4934431889864639
HS2024_5_I_N1,0.4994986703468654,,0.4686579733596448
HS2024_6_I_N1,0.5465055587436933,,0.5027188230419668
AR2021_KD 48h,,,
FR2021_Intensity.B,0.5042680503168332,,
RB2022_3_PreEndurance,,,
HS2024_5_I_T1,0.5187213910829652,,0.5274671753779889
NJH2024_Sub10_MICT_Pre,,,
SR2019_LM2_Biol_repl_2,,,
AST2020_anti-CD3,,,
SR2019_MDAMB231_Biol_repl_1,,,
RM2024_Intensity D2-3___3,,,
WZ2023_Pe_005_10min,0.6153912430449144,0.5030364395096166,0.5887692083069047
KBE2022_Log2_Ex_29_U,,,
HS2024_7_B_T1,0.6150751197874343,,0.5064847509159555
AH2018_LFQ_M_2_X,,,
AH2018_LFQ_IT_4_N,,0.49879065114310644,
CK2022_15 200-1,0.421275544905024,,0.5395966629530417
RM2024_Intensity D4-1___2,,,
JJ2018_Ratio H/M normalized,,,
JJ2018_Ratio M/L normalized pP3___1,,,
KBE2022_Log2_Ex_34_T,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,0.5625855821325869,,
LY2019_P2+,0.7839524761450624,,0.5978632274903031
LATM2013_Log2 Ratio (Light/Medium) Reverse,,,
CK2022_2 200-1,0.4879455034949471,,0.5324352938654046
AS2011_Ratio H/L Protein RNAi_2,,,
MV2014_Ratio L/H normalized A3___1 (2 min),,,
WZ2023_Su_010_30min,0.632015741445824,0.49341859531133836,0.5957924368110838
RN2012_H01,,,
KTGR2014_Ratio-Rapa 2 mins,,,
EJN2021_2_Rest_Basal,,,
KS2014_Intensity pY_E5_3,,,
MM2018_Ratio H/L replicate 3,,,
EP2017_Pervanadate R#1 normalized log2 ratio,,,
HS2024_8_B_T3,0.4455402320915984,,0.519057165180292
YA2020_Reporter_intensity_Cancer_No.3,,,
KBE2022_Log2_Ex_44_U,,,
WZ2023_Pe_010_20min,0.6139013953904017,0.5052868317711914,0.5879707731380568
KS2014_Intensity pY_C6,,,
AS2011_Ratio H/L Normalized_3,,,
RCJD2014_15min_mean,,,
RB2022_3_PreStrength,,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,,
RCJD2014_10min_mean,,,
KS2014_Intensity C1,,,
FSO2013_Ratio H/M normalized Rep3___1,0.3481466236070571,,0.5282175312913456
AH2018_SILAC_M_3_C,,0.49911797602168234,
RKK2015_TNF-α+IKKb/TNF-α,0.630644453009944,,0.6078353504388693
RM2024_Intensity D0-3___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,,
AH2018_SILAC_M_2_C,,,
AH2018_SILAC_M_2_X,,,
KTGR2014_Ratio-Rapa 15 mins,,,
RM2024_Intensity D4-2___1,,,
KBE2022_Log2_Ex_15_T,,,
VOI2024_0.1uM 24 h_1 di,,,
WZ2023_Su_010_10min,0.6202813534787488,0.493026495563041,0.5943843717899371
PG2020_Intensity 6h_C,,,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,,
JJ2018_Ratio M/L normalized pP1___1,,,
AH2018_LFQ_M_3_N,,0.5134364465872389,
VOI2024_0.1uM 24 h_2 mono,,,
AH2018_TMTMS2_3_C,,,
CK2022_15 16-1,,,
CK2022_3 16-1,,,
LY2019_P4-,0.4532130910146526,,0.6154932612527736
FSO2013_Ratio H/L normalized Rep3___2,,,
KS2014_Intensity pY_PV2,,,
HS2024_3_I_N2,0.4420719935118148,,0.5102140446387184
GF2025_P8_Adh,0.4889726388382946,,0.5631772612664911
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,,
GF2025_P5_Sph,0.4632464397673677,,0.5606156387916811
CK2022_10 16-1,,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,,
VOI2024_0.1uM 2 h_2 di,,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,,
NJH2024_Sub2_HIIT_Mid,,,
AMK2021_45I_p3,,,
NJH2024_Sub13_HIIT_Mid,,,
DB2022_LFQ intensity R1.2,,,
DB2022_Intensity R1,,,
NJH2024_Sub12_MICT_Mid,,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,,
UK2020_HCM_4,,,
SAS2015_AZD/DMSO_Exp2,,,
IMM2018_normalised rep. int. CDK5L-1,,,
DB2022_LFQ intensity L2.2,,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,,
EP2017_Mitotic R#1 log2 ratio,,,
EJN2021_2_Ex_Basal,,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,,
KTGR2014_Ratio-Rapa 30 mins,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,0.6253061947553631,,
CF2017_FTE 16,0.4702579296369408,,
AR2021_L41 10 μM,,,
CF2017_EOC 2,0.3705750136587544,,
RB2022_6_PostEndurance,,,
AH2018_SILAC_1_N,,,
NJH2024_Sub10_HIIT_Pre,,,
AS2011_Ratio H/L Inhi_1_2,,,
UK2020_HCM_6,,,
RB2022_7_PreSprint,,,
NJH2024_Sub2_MICT_Pre,,,
HS2024_3_PD_T2,0.613649877738957,,0.5224973688459993
CK2022_6 16-1,,,
ZX2022_CB treated Replicate 1,,,
BS2014_Log2(Ratio H/L normalized Rep_3),0.3283697091034037,,
TM2022_mock.12h.C,0.4188810582016728,,0.5169003312907176
GRW2016_Ratio M/L normalized SILAC 5a___1,,,
HH2022_Reporter intensity 0,,,
RM2024_Intensity D2-2___2,,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,,
RB2022_1_PreStrength,,,
JJ2018_Ratio H/M normalized pP2___2,,,
AH2018_TMTMS2_2_X,,,
AR2021_L41 1 μM,,,
JJ2018_Ratio H/M normalized pP1___2,,,
AH2018_TMTMS2_1_N,,,
NJH2025_Sub10_MICT_Pre,,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,,
ZX2022_Control Replicate 3,,,
KS2014_Intensity C4,,,
AS2011_Ratio H/L Inhi_2,,,
KBE2022_Log2_Ex_18_T,,,
NJH2025_Sub9_MICT_Pre,,,
RCJD2014_20min_1,,,
MV2014_Ratio H/M normalized B2___1 (5 min),,,
FSO2013_Ratio M/L normalized Rep2___3,,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,,
SR2019_MCF10A_Biol_repl_3,,,
HS2024_7_B_T2,0.6794248013329707,,0.4800053584587669
SAS2015_PLX/DMSO_Exp3,,,
AMK2021_Ctrl_p5,,,
NJH2025_Sub2_HIIT_Mid,,,
AH2018_LFQ_M_3_C,,0.5244360370167744,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,0.5636734502598776,,
YA2020_Reporter_intensity_Cancer_No.2,,,
FSO2013_Ratio H/M normalized Rep2___3,,,
RB2022_8_PreSprint,,,
AH2018_SILAC_IT_3_C,,,
WZ2023_Pu_025_10min,0.6224170910787165,0.509254906271709,0.5937480048109717
RM2024_Intensity D2-2___3,,,
AS2011_Ratio H/L_1,,,
RCJD2014_10min_3,,,
FSO2013_Ratio M/L normalized Rep3___1,0.2776855929253821,,0.5117794425206237
SR2019_JIMT1_Biol_repl_4,0.1102566607086737,,
YP2020_Intensity C10_R2_mult_log2,,,
ZCP2016_Ratio H/L Rep 2,,,0.4972685058401176
CF2017_EOC 4,0.4646114137699881,,
JJ2018_Ratio H/L normalized pP1___1,,,
WZ2023_Pe_010_30min,0.6176070393931453,0.4883968964484414,0.5922847996670926
MV2014_Ratio L/M normalized B2___3 (30 min),,,
AH2018_LFQ_IT_3_N,,,
KS2014_Intensity C6,,,
ZQ2022_N3,,,
HW2015_Ratio H/L normalized Exp1,,,
CK2022_12 40-1,,,
NJH2024_Sub7_MICT_Pre,,,
ZX2022_Control Replicate 1,,,
JJ2018_Ratio H/M normalized pP1,,,
CK2022_16 40-1,,,
AH2018_SILAC_IT_2_C,,,
CK2022_5 40-1,,,
AH2018_LFQ_3_X,,0.5141627586696662,
UK2020_UA_3,,,
LY2019_P7-,,,0.6105873257232927
GF2025_P5_Adh,0.5555715305970454,,0.536816023003029
RB2022_1_PostStrength,,,
JAW2011_Ratio H/L LS1b,,,
FSO2013_Ratio H/L normalized Rep3___1,0.4486401199369778,,0.530949417273493
SR2019_HCC1954_Biol_repl_3,,,
CR2017_Ratio Replicate 2.2,0.6218384686669568,0.5266913339792687,0.5654562143324176
VOI2024_0.1uM 2 h_1 mono,,,
MV2014_Ratio L/M normalized A2___1 (10 min),,,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,,
CK2022_11 16-1,,,
ZQ2022_C1,,,
CR2017_Ratio Replicate 2.1,0.3922436799264887,,0.49799991153764545
PG2020_Intensity CT_B,,,
JJ2018_Ratio M/L normalized___2,,,
AH2018_SILAC_MR_1_N,,,
KS2014_Intensity pY_E5_1,,,
JW2021_Before_3,,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,,
MV2014_Ratio M/H normalized B3___3 (30 min),,,
FS2019_db/db1,,,
NJH2025_Sub9_HIIT_Pre,,,
JAW2011_Ratio H/L_1,,,
RCJD2014_20min_3,,,
AH2018_LFQ_3_C,,0.5100842632972031,
JJ2018_Ratio M/L normalized pP3___2,,,
AMK2021_45I_p1,,,
NJH2025_Sub8_HIIT_Post,,,
AH2018_LFQ_M_3_X,,0.527771620277338,
YA2020_Reporter_intensity_Cancer_No.4,,,
KS2014_Intensity pY_E5_2,,,
FSO2013_Ratio H/L normalized Rep1___3,,,
GF2025_P4_Sph,0.5020667961631421,,0.5937263981343008
RB2022_2_PreEndurance,,,
JW2021_Before_1,,,
KBE2022_Log2_Ex_25_T,,,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,,
MV2014_Ratio L/M normalized A2___2 (10 min),,,
JJ2018_Ratio M/L normalized___1,,,
FR2021_Intensity.H,0.5054089916251276,,
CK2022_14 16-1,,,
AST2020_anti-CD3+PDL2,,,
MV2014_Ratio M/L normalized B1___1 (5 min),,,
KBE2022_Log2_Ex_19_T,,,
KS2014_Intensity pY_N1,,,
RB2022_1_RecoveryEndurance,,,
FSO2013_Ratio H/M normalized Rep1___2,,,
HS2024_8_I_T1,0.4491713492713697,,0.5125409350605342
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,,
EP2017_Mitotic R#2 log2 ratio,,,
AH2018_TMTMS2_1_X,,,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,,
ZCP2016_Ratio H/L Rep 3,,,0.6522378895954006
AS2011_Ratio H/L Normalized RNAi_1_3,,,
SR2019_MCF10A_Biol_repl_1,,,
NJH2025_Sub8_MICT_Mid,,,
EJN2021_5_Ex_Ins,,,
HS2024_6_I_N2,0.4968538090968349,,0.4941642230001557
HH2022_Reporter intensity 4,,,
RBK2021_1326T Late,,,
TM2022_mock.12h.B,0.4394022977587447,,0.5216516890714424
NJH2024_Sub12_MICT_Pre,,,
RCJD2014_15min_3,,,
MV2014_Ratio L/H normalized B3___2 (5 min),,,
LG2023_Control-3_intensity,,,
JJ2018_Ratio H/L normalized pP3___2,,,
CF2017_FTE 15,0.4079759638865924,,
HS2024_4_I_T3,0.4515930229530738,,0.5971053988996644
AH2018_SILAC_1_X,,,
PG2020_Intensity 10h_B,,,
AH2018_TMTMS3_1_X,,,
CF2017_FTE 14,0.4259316846352101,,
NJH2024_Sub13_HIIT_Post,,,
RM2024_Intensity D6-3___3,,,
NJH2025_Sub7_HIIT_Pre,,,
RBK2021_1259T Early,,,
RKK2015_IKK+TNF-α/IKKb,0.7120720275632753,,0.732691761590266
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,,
PG2020_Intensity 6h_A,,,
SR2019_HCC1419_Biol_repl_3,0.3664810287106975,,
KBE2022_Log2_Ex_14_T,,,
EP2017_Untreated R#2 normalized log2 ratio,,,
RM2024_Intensity D0-2___1,,,
DB2022_Intensity L1,,,
LY2019_P5+,,,0.5390321857520195
HS2024_5_I_N2,0.4187173772425772,,0.468438653928216
SAS2015_PLX/AZD_Exp3,,,
EP2017_Pervanadate R#2 log2 ratio,,,
AS2011_Ratio H/L Normalized RNAi_2_1,,,
